INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 38 filers reported holding INFLARX NV in Q3 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,321 | -76.1% | 132,658 | -64.3% | 0.00% | -100.0% |
| Q2 2023 | $1,655,155 | +438933.2% | 371,111 | +205.0% | 0.00% | – |
| Q4 2022 | $377 | -99.9% | 121,693 | -2.2% | 0.00% | – |
| Q3 2022 | $328,000 | +10.4% | 124,403 | -39.3% | 0.00% | – |
| Q2 2022 | $297,000 | -7.2% | 204,871 | +17.1% | 0.00% | – |
| Q1 2022 | $320,000 | +384.8% | 175,005 | +1162.3% | 0.00% | – |
| Q4 2021 | $66,000 | -44.5% | 13,864 | -69.9% | 0.00% | – |
| Q3 2021 | $119,000 | +22.7% | 46,080 | +41.6% | 0.00% | – |
| Q2 2021 | $97,000 | -18.5% | 32,542 | +6.6% | 0.00% | – |
| Q1 2021 | $119,000 | -74.9% | 30,515 | -74.6% | 0.00% | -100.0% |
| Q4 2019 | $475,000 | +19.9% | 120,070 | -25.2% | 0.00% | 0.0% |
| Q3 2019 | $396,000 | -85.7% | 160,521 | -81.7% | 0.00% | -75.0% |
| Q2 2019 | $2,774,000 | +96.5% | 877,824 | +2249.1% | 0.00% | +100.0% |
| Q1 2019 | $1,412,000 | -46.2% | 37,368 | -48.2% | 0.00% | -50.0% |
| Q4 2018 | $2,624,000 | +25.2% | 72,153 | +18.1% | 0.00% | +33.3% |
| Q3 2018 | $2,096,000 | +9.4% | 61,073 | +2.8% | 0.00% | +50.0% |
| Q2 2018 | $1,916,000 | +80.2% | 59,415 | +17.1% | 0.00% | +100.0% |
| Q4 2017 | $1,063,000 | – | 50,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,766,038 | $56,955,000 | 17.85% |
| RA Capital Management | 1,967,148 | $63,441,000 | 4.12% |
| Cormorant Asset Management, LP | 1,487,265 | $47,964,000 | 3.55% |
| Redmile Group, LLC | 2,027,700 | $65,393,000 | 2.22% |
| EMORY UNIVERSITY | 77,554 | $2,501,000 | 1.66% |
| Eventide Asset Management | 275,000 | $8,869,000 | 0.37% |
| Birchview Capital, LP | 16,000 | $516,000 | 0.35% |
| Artal Group S.A. | 500,000 | $16,125,000 | 0.34% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,385,659 | $76,938,000 | 0.18% |
| Baker Brothers Advisors | 258,824 | $8,347,000 | 0.06% |